Ontology type: schema:ScholarlyArticle Open Access: True
2018-12
AUTHORSFei Tang, Xuexiang Du, Mingyue Liu, Pan Zheng, Yang Liu
ABSTRACTAntibodies to human CTLA-4 have been shown to induce long-lasting protection against melanoma. It is assumed that these antibodies cause tumor rejection by blocking negative signaling from the B7-CTLA-4 interactions to enhance priming of naïve T cells in the lymphoid organs. Recently, we reported that anti-CTLA-4 antibody Ipilimumab effectively induces tumor rejection in vivo although it blocks neither B7 transendocytosis by CTLA-4 nor CTLA-4 binding to immobilized or cell-associated B7. Using genetic model in which the anti-CTLA-4 antibodies are unable to engage more than 50% of CTLA-4, we demonstrated that saturating binding of CTLA-4 is not necessary for tumor rejection. Our results argue against B7-CTLA-4 blockade as the mechanism of action for the clinically effective Ipilimumab. Moreover, Ipilimumab induces tumor rejection even in the absence of de novo T cell priming in the lymphoid organs. Thus, our data are inconsistent with key provisions of the prevailing hypothesis on mechanism of action by anti-CTLA-4 antibodies. Furthermore, anti-CTLA-4 antibodies effectively induce depletion of regulatory T (Treg) cells in tumor microenvironment but not in the peripheral lymphoid organs, which is strictly dependent on Fc receptor on host cells. Based on these data and other recent publications on the subject, we propose that anti-human CTLA-4 antibodies induce tumor rejection by selective depletion of Tregs in the tumors rather than blockade of B7-CTLA-4 interaction in lymphoid organs. More... »
PAGES30
http://scigraph.springernature.com/pub.10.1186/s13578-018-0229-z
DOIhttp://dx.doi.org/10.1186/s13578-018-0229-z
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1103452662
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/29713453
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Immunology",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "University of Maryland, Baltimore",
"id": "https://www.grid.ac/institutes/grid.411024.2",
"name": [
"Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, 725 W Lombard Street, 21201, Baltimore, MD, USA"
],
"type": "Organization"
},
"familyName": "Tang",
"givenName": "Fei",
"id": "sg:person.01242576034.93",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242576034.93"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Maryland, Baltimore",
"id": "https://www.grid.ac/institutes/grid.411024.2",
"name": [
"Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, 725 W Lombard Street, 21201, Baltimore, MD, USA"
],
"type": "Organization"
},
"familyName": "Du",
"givenName": "Xuexiang",
"id": "sg:person.011534352000.33",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011534352000.33"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Maryland, Baltimore",
"id": "https://www.grid.ac/institutes/grid.411024.2",
"name": [
"Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, 725 W Lombard Street, 21201, Baltimore, MD, USA"
],
"type": "Organization"
},
"familyName": "Liu",
"givenName": "Mingyue",
"id": "sg:person.013127313000.36",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013127313000.36"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "OncoImmune (United States)",
"id": "https://www.grid.ac/institutes/grid.417460.0",
"name": [
"Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, 725 W Lombard Street, 21201, Baltimore, MD, USA",
"OncoImmune, Inc., 9430 Key West Avenue, 20850, Rockville, MD, USA"
],
"type": "Organization"
},
"familyName": "Zheng",
"givenName": "Pan",
"id": "sg:person.011776060217.95",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011776060217.95"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "OncoImmune (United States)",
"id": "https://www.grid.ac/institutes/grid.417460.0",
"name": [
"Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, 725 W Lombard Street, 21201, Baltimore, MD, USA",
"OncoImmune, Inc., 9430 Key West Avenue, 20850, Rockville, MD, USA"
],
"type": "Organization"
},
"familyName": "Liu",
"givenName": "Yang",
"id": "sg:person.015554657644.90",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015554657644.90"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1084/jem.20130573",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1025992711"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/2326-6066.cir-13-0013",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1027403606"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0065-2776(06)90008-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037003471"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2004-07-2561",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037363769"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1084/jem.20130579",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1039859570"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2005-06-2298",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042865724"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.4049/jimmunol.171.11.6251",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1076602222"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/s41422-018-0011-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1101165607",
"https://doi.org/10.1038/s41422-018-0011-0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/s41422-018-0011-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1101165607",
"https://doi.org/10.1038/s41422-018-0011-0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/s41422-018-0011-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1101165607",
"https://doi.org/10.1038/s41422-018-0011-0"
],
"type": "CreativeWork"
}
],
"datePublished": "2018-12",
"datePublishedReg": "2018-12-01",
"description": "Antibodies to human CTLA-4 have been shown to induce long-lasting protection against melanoma. It is assumed that these antibodies cause tumor rejection by blocking negative signaling from the B7-CTLA-4 interactions to enhance priming of na\u00efve T cells in the lymphoid organs. Recently, we reported that anti-CTLA-4 antibody Ipilimumab effectively induces tumor rejection in vivo although it blocks neither B7 transendocytosis by CTLA-4 nor CTLA-4 binding to immobilized or cell-associated B7. Using genetic model in which the anti-CTLA-4 antibodies are unable to engage more than 50% of CTLA-4, we demonstrated that saturating binding of CTLA-4 is not necessary for tumor rejection. Our results argue against B7-CTLA-4 blockade as the mechanism of action for the clinically effective Ipilimumab. Moreover, Ipilimumab induces tumor rejection even in the absence of de novo T cell priming in the lymphoid organs. Thus, our data are inconsistent with key provisions of the prevailing hypothesis on mechanism of action by anti-CTLA-4 antibodies. Furthermore, anti-CTLA-4 antibodies effectively induce depletion of regulatory T (Treg) cells in tumor microenvironment but not in the peripheral lymphoid organs, which is strictly dependent on Fc receptor on host cells. Based on these data and other recent publications on the subject, we propose that anti-human CTLA-4 antibodies induce tumor rejection by selective depletion of Tregs in the tumors rather than blockade of B7-CTLA-4 interaction in lymphoid organs.",
"genre": "research_article",
"id": "sg:pub.10.1186/s13578-018-0229-z",
"inLanguage": [
"en"
],
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.2457087",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2482137",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2448699",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1045176",
"issn": [
"2045-3701"
],
"name": "Cell & Bioscience",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "8"
}
],
"name": "Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?",
"pagination": "30",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"13a3f88abb4b69b2f1b673abbaf377c5926e8d5aacb981a4d36c877e94bccbfd"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"29713453"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"101561195"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/s13578-018-0229-z"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1103452662"
]
}
],
"sameAs": [
"https://doi.org/10.1186/s13578-018-0229-z",
"https://app.dimensions.ai/details/publication/pub.1103452662"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-11T09:32",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000346_0000000346/records_99806_00000004.jsonl",
"type": "ScholarlyArticle",
"url": "https://link.springer.com/10.1186%2Fs13578-018-0229-z"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13578-018-0229-z'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13578-018-0229-z'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13578-018-0229-z'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13578-018-0229-z'
This table displays all metadata directly associated to this object as RDF triples.
131 TRIPLES
21 PREDICATES
37 URIs
21 LITERALS
9 BLANK NODES